Cell Cryopreservation Market

The growing adoption of automated cryopreservation systems is driving the market growth

The efficiency and reproducibility of cryopreservation methods are increased when automated cryopreservation devices precisely control freezing and thawing procedures. This dependability is essential for preserving cell viability and performance, which fuels the need for automated systems in clinical, commercial, and research settings. Automation makes it possible to standardize cryopreservation procedures, which lowers sample variability and increases sample quality consistency. Large-scale biobanking projects, the production of cell therapies, and high-throughput research applications depend on this standardization, which propels the uptake of automated systems.

Compared to manual procedures, automated cryopreservation systems offer great throughput and scalability since they can handle numerous samples simultaneously. This feature boosts productivity and efficiency and is especially useful for biobanks, cell production plants, and research labs handling huge samples.

Biobanks play a crucial role in the storage and preservation of biological samples, such as tissues and cells, for research and therapeutic applications. Economically developed nations had at least 11 biobanks per million persons in 2022, according to the National Library of Medicine, thus driving the Cell Cryopreservation market revenue.

The Global Cell Cryopreservation Market Industry benefits from a marked increase in investments directed towards biobanking initiatives. Biobanks play a crucial role in the collection, storage, and distribution of biological samples, including cells, for research and therapeutic purposes. As the demand for personalized medicine rises, the need for well-established biobanks becomes evident. Governments and private entities are allocating resources to enhance biobanking infrastructure, thereby facilitating the growth of the cryopreservation market. This trend is expected to contribute significantly to the market's expansion, with projections indicating a rise to 130.7 USD Billion by 2035.

The Global Cell Cryopreservation Market Industry experiences a notable surge in demand driven by advancements in regenerative medicine. As therapies utilizing stem cells and other cellular therapies gain traction, the need for effective preservation methods becomes paramount. Cryopreservation allows for the long-term storage of cells, ensuring their viability for future therapeutic applications. This trend is particularly evident in regions with robust healthcare infrastructure, where investments in regenerative medicine are increasing. The market is projected to reach 13.4 USD Billion in 2024, reflecting the growing recognition of cryopreservation's role in enhancing treatment outcomes.

The Global Cell Cryopreservation Market Industry is increasingly driven by its applications in drug development processes. Pharmaceutical companies utilize cryopreserved cells for high-throughput screening, toxicity testing, and the development of novel therapeutics. The ability to store and retrieve viable cells allows for more efficient and reproducible research outcomes. As the pharmaceutical sector continues to evolve, the reliance on cryopreservation techniques is likely to intensify. This trend not only supports the growth of the market but also enhances the overall efficiency of drug development pipelines, thereby contributing to the industry's long-term sustainability.

Regulatory bodies worldwide are increasingly recognizing the importance of cell preservation practices, thereby positively impacting the Global Cell Cryopreservation Market Industry. Guidelines and frameworks established by health authorities facilitate the safe and effective use of cryopreserved cells in clinical applications. This regulatory support encourages research institutions and healthcare providers to adopt cryopreservation techniques, ensuring compliance with safety standards. As regulations evolve to accommodate advancements in technology, the market is poised for growth. The alignment of regulatory frameworks with industry practices may further enhance the credibility and acceptance of cryopreservation methods in various applications.

Innovations in cryopreservation technologies significantly influence the Global Cell Cryopreservation Market Industry. Enhanced methods, such as vitrification and controlled-rate freezing, improve cell viability and recovery rates post-thaw. These advancements not only optimize the preservation process but also expand the range of cell types that can be effectively cryopreserved. As research institutions and biobanks adopt these cutting-edge techniques, the market is likely to witness substantial growth. The anticipated compound annual growth rate of 23.0% from 2025 to 2035 underscores the potential of these technological developments in shaping the future landscape of cell preservation.

By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American cell cryopreservation market will dominate this market, owing to the cell cryopreservation market in North America, which is distinguished by a focus on technological innovation and a high level of research into cryopreservation techniques. The region is experiencing a rise in demand for cryoprotectants and advanced freezing procedures because of the growing popularity of personalized medicine and a strong biomedical research sector.

The swift advancement of cryopreservation technology in North America can be attributed to the strategic partnerships between academic institutes and industrial companies.

Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, and South Korea.

Figure 2:  Cell Cryopreservation Market Share By Region 2023 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe's Cell Cryopreservation market accounts for the second-largest market share. The market for cell cryopreservation in Europe reflects the region's progressive nature, with a significant focus on environmentally friendly methods. Research collaborations and investments are increasing in the region, leading to breakthroughs in cryopreservation technology. A growing acceptance of serum-free cryopreservation techniques and strict adherence to regulatory requirements characterize Europe's approach. The market is distinguished by its dedication to moral and superior cell preservation techniques, consistent with the area's emphasis on expanding biological sciences.

Further, the German Cell Cryopreservation market held the largest market share, and the UK Cell Cryopreservation market was the fastest-growing market in the European region.

The Asia-Pacific Cell Cryopreservation Market is expected to grow at the fastest CAGR from 2025 to 2034. The cell cryopreservation market in Asia-Pacific is exhibiting dynamic trends, with a noticeable emphasis on expanding biobanking activities and the growing influence of regenerative medicine. Growing awareness of stem cell applications and a thriving healthcare sector are driving demand for cryopreservation technologies in growing economies in the region. The adoption of automated cryopreservation systems is on the rise throughout Asia, demonstrating a forward-thinking approach to technological integration in cell preservation.

Moreover, China’s Cell Cryopreservation market held the largest market share, and the Indian Cell Cryopreservation market was the fastest-growing market in the Asia-Pacific region.

The Cell Cryopreservation market will continue to grow as major companies in the industry make significant R&D investments to extend their Type ranges. Significant market developments include new Type releases, contractual agreements, mergers and acquisitions, greater investments, and cooperation with other organizations. Market participants also engage in various strategic actions to broaden their  footprint. The Cell Cryopreservation sector must provide affordable Types to grow and thrive in a more cutthroat and dynamic market.

Local manufacturing to lower operating costs is one of the key strategies manufacturers use in the  Cell Cryopreservation market to benefit consumers and grow the market sector. Some of the biggest medical benefits in recent years have come from the Cell Cryopreservation sector. Major players in the Cell Cryopreservation market, including Thermo Fisher Scientific Inc., VWR International LLC, STEMCELL Technologies Inc., Merck KGaA, GE Healthcare Life Sciences, BioLife Solutions Inc., Avantor Inc., Biocision LLC, Cesca Therapeutics Inc., Chart Industries Inc., Custom Biogenic Systems Inc., Worthington Industries Inc., Hamilton Company, Becton, Dickinson and Company, Brooks Automation Inc., ZENOAQ RESOURCE CO.

LTD., and Aivita Biomedical, and others are attempting to increase market demand by investing in research and development operations.

A life sciences business called Biolife Solutions Inc. (BioLife Solutions) creates and produces instruments for bioproduction. The company sells items related to cell processing, such as cryogenic vials, human platelet lysate media, automated fill equipment for cell processing, and biopreservation media. It provides cryogenic freezers and accessories, automated thawing equipment, ultra-low temperature freezers, and thawing systems. BioLife Solutions also offers cold chain and storage solutions, including cloud-connected shipping containers and biological and pharmaceutical materials storage. The company sells its goods under several brands, including HypoThermosol, ThawSTAR, Nliven PR, Nliven PR, and Stemulate.

Leading provider of equipment and services for cell and gene therapy bioproduction, BioLife Solutions, Inc., stated in May 2021 that it had completed the previously disclosed acquisition of Stirling Ultracold, a privately held producer of mechanical freezers with ultra-low temperatures (ULTs). About 100 energy-efficient ULT mechanical freezers will be supplied by Stirling to help customers with their cold chain capabilities for biologics and cutting-edge modalities.

Millions of people are impacted daily by their sophisticated technology, sophisticated analytics, and artificial intelligence. Leading innovator in digital solutions and medical technology worldwide, GE HealthCare uses its Edison intelligence platform to power intelligent devices, data analytics, apps, and services that help physicians make better decisions more quickly. The company, which employs about 50,000 people worldwide and has over a century of experience in the healthcare sector, is at the hub of an ecosystem that aims to digitize healthcare, advance precision health, increase productivity, and enhance outcomes for patients, providers, health systems, and researchers worldwide.

They strive to build a world where healthcare has no bounds and promote a culture of respect, openness, integrity, and diversity.